These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38607328)

  • 1. Long-term prognostic value of the H
    Ishizu K; Shirai S; Isotani A; Hayashi M; Tabata H; Ohno N; Kakumoto S; Ando K; Yashima F; Tada N; Yamawaki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    ESC Heart Fail; 2024 Aug; 11(4):2159-2171. PubMed ID: 38607328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the H
    Ludwig S; Pellegrini C; Gossling A; Rheude T; Voigtländer L; Bhadra OD; Linder M; Kalbacher D; Koell B; Waldschmidt L; Schirmer J; Seiffert M; Reichenspurner H; Blankenberg S; Westermann D; Conradi L; Joner M; Schofer N
    ESC Heart Fail; 2021 Feb; 8(1):461-470. PubMed ID: 33215870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of In-Hospital Mortality after Transcatheter Aortic Valve Implantation.
    Krittanawong C; Kumar A; Wang Z; Johnson KW; Rastogi U; Narasimhan B; Kaplin S; Virk HUH; Baber U; Tang W; Lansky AJ; Stone GW
    Am J Cardiol; 2020 Jan; 125(2):251-257. PubMed ID: 31759517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Prognostic Value of the Society of Thoracic Surgery Risk Score in Patients Undergoing Transcatheter Aortic Valve Implantation (From the OCEAN-TAVI Registry).
    Ishizu K; Shirai S; Isotani A; Hayashi M; Kawaguchi T; Taniguchi T; Ando K; Yashima F; Tada N; Yamawaki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    Am J Cardiol; 2021 Jun; 149():86-94. PubMed ID: 33753041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the clinical frailty scale on long-term outcomes after transcatheter aortic valve implantation.
    Miyawaki N; Ishizu K; Shirai S; Miyahara K; Yamamoto K; Suenaga T; Otani A; Nakano K; Fukushima T; Ko E; Tsuru Y; Nakamura M; Morofuji T; Morinaga T; Hayashi M; Isotani A; Ohno N; Kakumoto S; Ando K
    Am Heart J; 2024 Sep; 275():141-150. PubMed ID: 38876408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less.
    Adamo M; Fiorina C; Petronio AS; Giannini C; Tamburino C; Barbanti M; Bedogni F; Testa L; Colombo A; Latib A; Bruschi G; Reimers B; Poli A; Nazzaro MS; Curello S; Ettori F
    Am J Cardiol; 2018 Nov; 122(10):1718-1726. PubMed ID: 30227961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Risk Scores Applied to Transcatheter Aortic Valve Implantation: Friends or Foes? Short-Term and Long-Term Outcomes From a Single-Center Registry.
    Compagnone M; Moretti C; Marcelli C; Taglieri N; Ghetti G; Corsini A; Bruno M; Bruno AG; Orzalkiewicz M; Marrozzini C; Bacchi Reggiani ML; Palmerini T; Saia F
    J Invasive Cardiol; 2019 Oct; 31(10):E282-E288. PubMed ID: 31567116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H2FPEF Score as a Prognostic Value in HFpEF Patients.
    Sueta D; Yamamoto E; Nishihara T; Tokitsu T; Fujisue K; Oike F; Takae M; Usuku H; Takashio S; Arima Y; Suzuki S; Nakamura T; Ito M; Kanazawa H; Sakamoto K; Kaikita K; Tsujita K
    Am J Hypertens; 2019 Oct; 32(11):1082-1090. PubMed ID: 31271191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HFA-PEFF score: prognosis in patients with preserved ejection fraction after transcatheter aortic valve implantation.
    Seoudy H; von Eberstein M; Frank J; Thomann M; Puehler T; Lutter G; Lutz M; Bramlage P; Frey N; Saad M; Frank D
    ESC Heart Fail; 2022 Apr; 9(2):1071-1079. PubMed ID: 35092186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Low-Flow Severe Aortic Stenosis in Small-Body Patients Undergoing TAVR: The OCEAN-TAVI Registry.
    Kataoka A; Watanabe Y; Kozuma K; Nara Y; Nagura F; Kawashima H; Hioki H; Nakashima M; Yamamoto M; Takagi K; Araki M; Tada N; Shirai S; Yamanaka F; Hayashida K;
    JACC Cardiovasc Imaging; 2018 May; 11(5):659-669. PubMed ID: 28528156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Aortic Valve Implantation vs. Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Real-World Clinical Practice.
    Takeji Y; Taniguchi T; Morimoto T; Saito N; Ando K; Shirai S; Sakaguchi G; Arai Y; Fuku Y; Kawase Y; Komiya T; Ehara N; Kitai T; Koyama T; Watanabe S; Watanabe H; Shiomi H; Minamino-Muta E; Matsuda S; Yaku H; Yoshikawa Y; Yamazaki K; Kawatou M; Sakamoto K; Tamura T; Miyake M; Sakaguchi H; Murata K; Nakai M; Kanamori N; Izumi C; Mitsuoka H; Kato M; Hirano Y; Inada T; Nagao K; Mabuchi H; Takeuchi Y; Yamane K; Tamura T; Toyofuku M; Ishii M; Inoko M; Ikeda T; Ishii K; Hotta K; Jinnai T; Higashitani N; Kato Y; Inuzuka Y; Morikami Y; Minatoya K; Kimura T;
    Circ J; 2020 Apr; 84(5):806-814. PubMed ID: 32009065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
    Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
    BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome.
    Denegri A; Mehran R; Holy E; Taramasso M; Pasotti E; Pedrazzini G; Moccetti T; Maisano F; Nietlispach F; Obeid S
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):141-148. PubMed ID: 30269398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI.
    Ludwig S; Goßling A; Seiffert M; Westermann D; Sinning JM; Sugiura A; Adam M; Mauri V; Frank D; Seoudy H; Rudolph T; Potratz M; Conradi L; Schofer N
    Open Heart; 2022 Jan; 9(1):. PubMed ID: 34987075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure hospitalization following surgical or transcatheter aortic valve implantation in low-risk aortic stenosis.
    Lopez-Martinez H; Vilalta V; Farjat-Pasos J; Ferrer-Sistach E; Mohammadi S; Escabia C; Kalavrouziotis D; Resta H; Borrellas A; Dumont E; Carrillo X; Paradis JM; Fernández-Nofrerías E; Delgado V; Rodés-Cabau J; Bayes-Genis A
    ESC Heart Fail; 2024 Oct; 11(5):2531-2541. PubMed ID: 38894578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
    Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
    Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter Aortic Valve Implantation in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis.
    Rodriguez-Gabella T; Nombela-Franco L; Auffret V; Asmarats L; Islas F; Maes F; Ferreira-Neto AN; Paradis JM; Dumont E; Côté M; Jiménez-Quevedo P; Macaya C; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2018 Aug; 122(4):625-632. PubMed ID: 30064863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
    Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
    Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Patients at Estimated Low, Intermediate, and High Risk Undergoing Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Barbash IM; Finkelstein A; Barsheshet A; Segev A; Steinvil A; Assali A; Ben Gal Y; Vaknin Assa H; Fefer P; Sagie A; Guetta V; Kornowski R
    Am J Cardiol; 2015 Dec; 116(12):1916-22. PubMed ID: 26602076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis.
    Brízido C; Madeira M; Brito J; Madeira S; Campante Teles R; Raposo L; Mesquita Gabriel H; Nolasco T; de Araújo Gonçalves P; Sousa-Uva M; Abecasis M; de Sousa Almeida M; Neves JP; Mendes M
    Catheter Cardiovasc Interv; 2021 Dec; 98(7):E1033-E1043. PubMed ID: 34506074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.